Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Oxford Biomedica raises £60m to bolster US capacity

(Sharecast News) - Oxford Biomedica has raised £60m via a share placing and subcription to expand its US operations, the gene and cell therapy company announced on Friday. A total of 12.21m shares were placed at a price of 431p each, slightly below Thursday's closing price of 439.50p, while certain existing shareholders subscribed for 1.71m shares.

In total, the placing and subscription represented 13.1% of the issued share capital of the company.

OXB said the net proceeds from the fundraising would go towards expanding its US commercial-scale capacity and advancing process quality, productivity and yields.

"This will allow the Company to address growing client demand including visible near and medium-term opportunities across all clinical phases, including late-stage and commercial supply," OXB said.

Shares were up 1.9% at 447.83p by 0919 BST.

Share this article

Related Sharecast Articles

PE firm Arcline not planning to bid for Senior
(Sharecast News) - Private equity firm Arcline Investment Management said on Wednesday that it does not intend to make an offer for engineer Senior.
JPMorgan American Investment Trust reports positive but lagging performance
(Sharecast News) - JPMorgan American Investment Trust reported a positive but lagging performance in 2025 on Wednesday, as its quality-focused investment approach underperformed a market driven by higher-risk stocks, while the board struck an optimistic tone on the outlook for US equities.
Topps Tiles to shut 23 stores in cost-saving bid
(Sharecast News) - Topps Tiles announced plans to shut 23 underperforming stores on Wednesday as the tile specialist looks to save costs.
Berenberg downgrades Future to 'hold', slashes target price
(Sharecast News) -

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.